[go: up one dir, main page]

ZA957140B - Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants and its use - Google Patents

Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants and its use

Info

Publication number
ZA957140B
ZA957140B ZA957140A ZA957140A ZA957140B ZA 957140 B ZA957140 B ZA 957140B ZA 957140 A ZA957140 A ZA 957140A ZA 957140 A ZA957140 A ZA 957140A ZA 957140 B ZA957140 B ZA 957140B
Authority
ZA
South Africa
Prior art keywords
antidote
employment
pharmaceutical
blood anticoagulants
anticoagulants
Prior art date
Application number
ZA957140A
Inventor
Juergen Roemisch
Karl-Heinz Diehl
Hans-Arnold Stoehr
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ZA957140B publication Critical patent/ZA957140B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA957140A 1994-08-26 1995-08-25 Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants and its use ZA957140B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4430204A DE4430204A1 (en) 1994-08-26 1994-08-26 Medicament, which is suitable as an antidote for blood anticoagulants and its use

Publications (1)

Publication Number Publication Date
ZA957140B true ZA957140B (en) 1996-03-26

Family

ID=6526563

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA957140A ZA957140B (en) 1994-08-26 1995-08-25 Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants and its use

Country Status (8)

Country Link
EP (1) EP0700682A3 (en)
JP (1) JP3838680B2 (en)
KR (1) KR960006920A (en)
AU (1) AU708409B2 (en)
CA (1) CA2156990A1 (en)
DE (1) DE4430204A1 (en)
IL (1) IL115057A0 (en)
ZA (1) ZA957140B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19625642A1 (en) * 1996-06-26 1998-01-08 Max Planck Gesellschaft A process for preparing an antidote precursor for natural and synthetic thrombin inhibitors
KR20030031380A (en) * 2001-10-13 2003-04-21 이우진 Skateboard
JPWO2003099324A1 (en) * 2002-05-23 2005-09-22 中外製薬株式会社 Tissue factor inhibitor neutralizing agent and active blood coagulation factor VII neutralizing agent
KR20040046045A (en) * 2002-11-26 2004-06-05 김재영 Paduk board and chess board that use copper material and maunfacturing method thereof
GB0324044D0 (en) 2003-10-14 2003-11-19 Astrazeneca Ab Protein
KR20130140221A (en) 2005-04-13 2013-12-23 아스트라제네카 아베 A host cell comprising a vector for production of proteins requiring gamma-carboxylation
US8206967B2 (en) 2007-07-06 2012-06-26 Medimmune Limited Method for production of recombinant human thrombin
US9433664B2 (en) 2010-10-06 2016-09-06 Medimmune Limited Factor II and fibrinogen for treatment of haemostatic disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5850202B2 (en) * 1977-11-10 1983-11-09 第一製薬株式会社 Production method of prothrompin
DE3043857A1 (en) * 1980-11-21 1982-07-08 Behringwerke Ag, 3550 Marburg METHOD FOR THE PRODUCTION OF BLOOD coagulation FACTORS AND THE PREPARATION OF FACTORS II AND VII THEREFORE PRODUCED
DD251078A1 (en) * 1986-07-17 1987-11-04 Bezirksinstitut Fuer Blutspend PROCESS FOR THE PREPARATION OF PROTHROMBIN CONCENTRATES
GB8729822D0 (en) * 1987-12-22 1988-02-03 Central Blood Lab Authority Chemical process
EP0333356A3 (en) 1988-03-04 1990-12-19 Biogen, Inc. Hirudin peptides
JPH0219400A (en) * 1988-07-07 1990-01-23 Green Cross Corp:The Method for producing thrombin or prothrombin
US5240913A (en) 1989-08-18 1993-08-31 Biogen, Inc. Inhibitors of thrombin
DE69101634D1 (en) * 1990-01-26 1994-05-11 Immuno Ag Wien RECOMBINANTLY PRODUCED BLOOD FACTORS, METHOD FOR EXPRESSING SUCH BLOOD FACTORS AND RECOMBINANT VACCINA VIRUS USED IN THIS PROCESS.
DE4203965A1 (en) * 1992-02-11 1993-08-12 Max Planck Gesellschaft ANTIDOT FOR HIRUDIN AND SYNTHETIC THROMBIN INHIBITORS
AT397391B (en) * 1992-05-15 1994-03-25 Immuno Ag USE OF PROTHROMIN FRAGMENTS

Also Published As

Publication number Publication date
JPH0859505A (en) 1996-03-05
EP0700682A3 (en) 1996-05-29
IL115057A0 (en) 1995-12-08
AU708409B2 (en) 1999-08-05
JP3838680B2 (en) 2006-10-25
EP0700682A2 (en) 1996-03-13
DE4430204A1 (en) 1996-02-29
KR960006920A (en) 1996-03-22
CA2156990A1 (en) 1996-02-27
AU3025695A (en) 1996-03-07

Similar Documents

Publication Publication Date Title
EP0960628A4 (en) Syringe serving also as an ampule and syringe for collecting blood
CY2007001I1 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
BR9007323A (en) GORGE
GB2220143B (en) Single-use syringe
PT934057E (en) MEDICAL FORMULATIONS OF AEROSOLS WITH FORMOTEROL
GB2213383B (en) Single-use syringe
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
IL93843A0 (en) Disposable syringe
ZA957139B (en) Compositions which are suitable for employment as antidotes to blood anticoagulants and their use
AU6068290A (en) Invalid walker
GB9414143D0 (en) Improvements relating to blood sampling devices
ZA957140B (en) Pharmaceutical which is suitable for employment as an antidote to blood anticoagulants and its use
AU4967290A (en) Single-use syringe
EP0433250A3 (en) Disposable syringe
AU4821190A (en) Disposable hypodermic syringe
PL304799A1 (en) Disposable syringe
AU5223490A (en) Non reusable hypodermic syringe
AU593513B3 (en) Disposable hypodermic syringe
GB9413010D0 (en) Novel types of medical use for nystatin
TW320056U (en) Novel structure of safe syringe
GB8915253D0 (en) Medicament for application to damaged skin
AU3440489A (en) Single-use syringe
BR8703509A (en) HUMAN BLOOD EVIDENCE
ZA935120B (en) Medicinal compositions for the improvement of blood coagulation comprising TCF-II
RU1769893C (en) Device for skin application of drugs